Document is current
Any future updates will be listed below
-
Authors
Liu, Enze
Jaouadi, Oumaima
Sharma, Riya
Becker, Nathan
Johnson, Travis S.
Sudha, Parvathi
Chopra, Vivek S.
Zafar, Faiza
Hamidi, Habib
Pawlyn, Charlotte
Suvannasankha, Attaya
Abonour, Rafat
Walker, Brian A.
-
Funding
Funding for this research was provided by:
Multiple Myeloma Research Foundation
Genentech
Melvin and Bren Simon Cancer Center, Indiana University (CA082709)
International Myeloma Society
- License Information
-
More Information
Article History
Received: 3 February 2025
Accepted: 24 June 2025
First Online: 15 July 2025
Declarations
:
: Ninety-four (44 newly diagnosed and 50 relapsed) samples in IU dataset were collected as part of the Indiana Myeloma Registry, a prospective, non-interventional, observational study (NCT03616483) where patients gave informed consent for use of samples for research purposes. The study was approved by Indiana University IRB (#1804208190). All research conformed with the principles of the Declaration of Helsinki.
: Not applicable.
: V.S.C., H.H., F.Z. and M.N. are employed by and hold stock in Genentech Inc. The remaining authors declare that they have no competing interests.
